
FDA adds new warning on GLP-1 drugs for rare eye condition
The U.S. Food and Drug Administration announced Monday that it is requiring new warnings on popular diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a potential increased risk for a rare eye condition that can cause permanent vision loss.
ABC News' Dr. Darien Sutton has the latest.
ABC News' Dr. Darien Sutton has the latest.
ABC News
ABC News is your daily source for breaking national and world news, exclusive interviews and 24/7 live streaming coverage that will help you stay up to date on the events shaping our world. https://abcnews.go.com...